An interventional study of Qigong and Daily 2 min pain management survey in Spinal Cord Injuries, sponsored by University of Minnesota. Recruiting at 3 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-19.
Sponsored by University of Minnesota · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Spinal Cord Injuries by University of Minnesota — 7 open to participants now, 7 under way, none of them phase 3. Spinal Cord Injuries · University of Minnesota.
Among the 15 studies in Spinal Cord Injuries by University of Minnesota, this one is the 6th largest by planned enrollment of the 12 interventional ones that give a count, is one of 2 that started in 2024, is one of 8 with no phase, and was the 12th registered.
2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.
Browse Spinal Cord Injuries studies →7 of the 15 studies in Spinal Cord Injuries by University of Minnesota are open now, in 1 country. Recruiting first, the newest first:
University of Minnesota · Sites in United States
Ages 22+
University of Minnesota · Sites in United States
Ages 18+ · Healthy volunteers
University of Minnesota · Sites in United States
Ages 22+
University of Minnesota · Sites in United States
Ages 22+
University of Minnesota · Sites in United States
Ages 22+
By country, each count listing its studies:
Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 3 · Phase 3 1
First in 2015; this study’s year is marked. 2 started in 2024.
This study's planned enrollment of 40 is above the median of 24 across 1,639 interventional studies indexed under Spinal Cord Injuries.
Median enrollment 38 across the 12 interventional studies, 113 across the 3 observational. Of the 8 that completed or were terminated, 2 (25%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Minnesota is the lead sponsor of 1,219 studies on the registry; 199 are open to participants now.
Of its 136 completed or terminated interventional studies of FDA-regulated products, 95 (70%) have results posted.
4 of the studies in Spinal Cord Injuries by University of Minnesota that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03026816University of MinnesotaEpidural Stimulation After Neurologic Damage | 2027-01 |
| NCT06140355University of MinnesotacHAnging the Perceived Pain INtensity in divErSe Populations With Spinal Cord Injury | 2027-01-31 |
| NCT07029802University of MinnesotaDevelopment of a Novel Evaluation Scale of Mental Body Representation (MBR) for Adults With Spinal Cord Injury | 2027-06-15 |
| NCT05741788University of MinnesotaThe Teaspoon Study - Telefitting Spinal Cord Stimulation for Pain | 2027-10-01 |
Add all 4 to your calendar (.ics) → With an account.
Among the 15 studies in Spinal Cord Injuries by University of Minnesota, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Chronic neuropathic pain affects 69% of adults with spinal cord injury (SCI). Current treatment options are limited (primarily pain medications) with insufficient benefits and significant risks for addiction and adverse effects. Of the available mind and body approaches, Qigong is the most accessible for adults with SCI with evidence for effectiveness in reducing pain, but there is insufficient evidence to make recommendations for adults with SCI. Thus, the feasibility of Qigong in SCI needs to be established.
To support our feasibility study, we investigated a 12-week remote Qigong program in adults with SCI and neuropathic pain. We recruited 23 adults with SCI, 18 completed the study, and 12 completed the 1-year follow-up. They practiced Qigong 138% of the required intensity (which was, at least 3x/week with Qigong video through the internet). Their pain was reduced by 44% after 12 weeks of Qigong practice and was still reduced at the 6-week and 1-year follow-up. However, three key elements need to be addressed before performing a larger effectiveness study: (1) feasibility/acceptability of Qigong from adults with SCI of diverse backgrounds; (2) feasibility of the study design with control group); and (3) objective outcome measures.
This R34 feasibility study, the HAPPINESS trial (cHAnging the Perceived Pain INtensity in divErSe populations with Spinal cord injury), will expand on our prior study to consolidate feasibility with a rigorous protocol. We will address the following aims: AIM 1. Identify the facilitators/barriers to participating in a Qigong study through focus groups/interviews with stakeholders from diverse backgrounds, defined as Hispanics, veterans, and adults living in rural, underserved areas. AIM 2. Establish the feasibility of study design/methods of the HAPPINESS trial in adults with SCI (at least 50% of diverse backgrounds) through pre-specified targets for recruitment/enrollment, feasibility, and acceptability of design and outcomes. Using a Phase I randomized controlled trial design, 40 adults with SCI-related neuropathic pain will be randomized to 12-week remote Qigong intervention OR a short daily pain management survey that can be completed on phone/iPad/computer + 6-month follow-up. The study results will facilitate a rigorous structure to design larger effectiveness studies and facilitate a clear pathway for researchers to investigate Qigong and other mind-body approaches for whole-person health in diverse groups of adults with chronic/neurological disorders.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
adults with SCI-related neuropathic pain with at least 50% from diverse groups randomized to experimental group
Behavioral: Qigong
adults with SCI-related neuropathic pain with at least 50% from diverse groups randomized to active comparator group
Behavioral: Daily 2 min pain management survey
a Qigong introduction class and a 12-week remote Qigong intervention, with a 6-month follow-up
Completing one short survey (2 min) daily through your phone or computer (you will get a survey link through email or text), with a 6-month follow-up.
recruitment rates
The proportion of potential participants contacted who agreed to participate
Time frame: 6 months post-intervention
the recruitment rate for complete and incomplete SCI
Ratio of complete/incomplete SCI.
Time frame: 6 months post-intervention
Attrition rates in Qigong and Manage My Pain app group.
Proportion of people withdrawing from the study in either group. Drop-out due to unrelated reasons will count as part of the general attrition.
Time frame: 6 months post-intervention
intervention adherence
the website log times will indicate the date and duration that the video is accessed. From this information, we will collect the number of minutes that they practice. This information will be checked with the self-report during the weekly calls, in which they will report the number of minutes per week they have practiced.
Time frame: 6 months post-intervention
the frequency of use of the Manage My Pain app (recommended daily check in)
Weekly/ monthly check-ins (reporting min/week of practice) to identify facilitators and barriers to practicing Qigong. The website logs time and duration of video access. A Qigong certified instructor will do 1:1 Qigong session with each participant via zoom monthly for quality control/to give guidance.
Time frame: 6 months post-intervention
Feasibility of adhering to the collection of quantitative measure 1
% Adherence in completing all assessments during the study and in the monthly follow-up phase
Time frame: 6 months post-intervention
Feasibility of adhering to the collection of quantitative measure 2
% Adherence to wearing Fitbit Charge 6 and sending the data through their phone App
Time frame: 6 months post-intervention
Started Aug 2024 (actual). Primary completion is estimated for Jan 2027, 29 months after the start.
Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 29 months is below that.
Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.